Question 1: For two anticancer agents that are small molecules from different groups in the biological and miscellaneous therapies category, state the drug class and compare their mechanisms of action.
Question 2: Compare these two drugs with respect to their dose limiting toxicities and major drug resistance mechanisms, and indicate whether this loss of selective toxicity is related to pharmacodynamic or pharmacokinetic mechanisms.